Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 enzymes, particularly CYP51/Erg11, are essential monooxygenases in the ergosterol biosynthesis pathway in fungi. They catalyze key oxidative demethylation reactions, converting lanosterol to ergosterol, a crucial component of fungal cell membranes. These enzymes are major targets for antifungal drugs like azoles, which disrupt membrane formation and lead to fungal cell death.
Inhibition of CYP51/Erg11, blocking demethylation of lanosterol
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 Enzyme (Ergosterol Biosynthesis) (None).